Spectroscopic imaging with spectral domain visible light optical coherence microscopy in Alzheimer’s disease brain samples

A visible light spectral domain optical coherence microscopy system was developed. A high axial resolution of 0.88 μm in tissue was achieved using a broad visible light spectrum (425 – 685 nm). Healthy human brain tissue was imaged to quantify the difference between white (WM) and grey matter (GM) in intensity and attenuation. The high axial resolution enables the investigation of amyloid-beta plaques of various sizes in human brain tissue and animal models of Alzheimer’s disease (AD). By performing a spectroscopic analysis of the OCM data, differences in the characteristics for WM, GM, and neuritic amyloid-beta plaques were found. To gain additional contrast, Congo red stained AD brain tissue was investigated. A first effort was made to investigate optically cleared mouse brain tissue to increase the penetration depth and visualize hyperscattering structures in deeper cortical regions.

[1]  Philippe Pouliot,et al.  Whole mouse brain imaging using optical coherence tomography: reconstruction, normalization, segmentation, and comparison with diffusion MRI , 2017, Neurophotonics.

[2]  Francisco E. Robles,et al.  Molecular imaging true-colour spectroscopic optical coherence tomography. , 2011, Nature photonics.

[3]  P. Marquet,et al.  In vivo local determination of tissue optical properties: applications to human brain. , 1999, Applied optics.

[4]  Ji Yi,et al.  Imaging a full set of optical scattering properties of biological tissue by inverse spectroscopic optical coherence tomography. , 2012, Optics letters.

[5]  E. Sigurdsson,et al.  In vivo magnetic resonance imaging of amyloid-β plaques in mice. , 2012, Methods in molecular biology.

[6]  Junfeng Zhu,et al.  Serial optical coherence scanner for large-scale brain imaging at microscopic resolution , 2014, NeuroImage.

[7]  R. Mantegna,et al.  Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Julia Gallwas,et al.  Effect of optical clearing agents on optical coherence tomography images of cervical epithelium , 2014, Lasers in Medical Science.

[9]  J. Johansson,et al.  Spectroscopic method for determination of the absorption coefficient in brain tissue. , 2010, Journal of biomedical optics.

[10]  Dan Zhu,et al.  Enhanced optical clearing of skin in vivo and optical coherence tomography in-depth imaging. , 2012, Journal of biomedical optics.

[11]  Ruopeng Wang,et al.  Polarization sensitive optical coherence microscopy for brain imaging. , 2016, Optics letters.

[12]  C K Hitzenberger,et al.  Spectral measurement of absorption by spectroscopic frequency-domain optical coherence tomography. , 2000, Optics letters.

[13]  A. Howie,et al.  Optical properties of amyloid stained by Congo red: history and mechanisms. , 2009, Micron.

[14]  V. Srinivasan,et al.  Optical coherence microscopy for deep tissue imaging of the cerebral cortex with intrinsic contrast , 2012, Optics express.

[15]  Adam Wax,et al.  Noise characterization of supercontinuum sources for low-coherence interferometry applications. , 2014, Journal of the Optical Society of America. A, Optics, image science, and vision.

[16]  Theo Lasser,et al.  Visible spectrum extended-focus optical coherence microscopy for label-free sub-cellular tomography. , 2017, Biomedical optics express.

[17]  H. Lemij,et al.  Depth-resolved model-based reconstruction of attenuation coefficients in optical coherence tomography. , 2013, Biomedical optics express.

[18]  Gerhard G. Paulus,et al.  Nanometer resolution optical coherence tomography using broad bandwidth XUV and soft x-ray radiation , 2016, Scientific Reports.

[19]  T. Row,et al.  Micellar aggregates and hydrogels from phosphonobile salts. , 2005, Organic & biomolecular chemistry.

[20]  O. Bang,et al.  A comparative study of noise in supercontinuum light sources for ultra-high resolution optical coherence tomography , 2017, BiOS.

[21]  Bernhard Baumann,et al.  Optical Coherence Tomography for Brain Imaging , 2019 .

[22]  Nick C Fox,et al.  Brain imaging in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[23]  Junfeng Zhu,et al.  Reconstructing micrometer-scale fiber pathways in the brain: Multi-contrast optical coherence tomography based tractography , 2011, NeuroImage.

[24]  Shau Poh Chong,et al.  Structural and functional human retinal imaging with a fiber-based visible light OCT ophthalmoscope. , 2017, Biomedical optics express.

[25]  Marc Flajolet,et al.  Three-Dimensional Study of Alzheimer's Disease Hallmarks Using the iDISCO Clearing Method. , 2016, Cell reports.

[26]  Ji Yi,et al.  Visible-Light Optical Coherence Tomography Angiography for Monitoring Laser-Induced Choroidal Neovascularization in Mice , 2016, Investigative ophthalmology & visual science.

[27]  Ji Yi,et al.  Human retinal imaging using visible-light optical coherence tomography guided by scanning laser ophthalmoscopy. , 2015, Biomedical optics express.

[28]  Shau Poh Chong,et al.  Noninvasive, in vivo imaging of subcortical mouse brain regions with 1.7  μm optical coherence tomography. , 2015, Optics letters.

[29]  A. Fercher,et al.  Submicrometer axial resolution optical coherence tomography. , 2002, Optics letters.

[30]  Shuliang Jiao,et al.  Visible-light optical coherence tomography-based multimodal retinal imaging for improvement of fluorescent intensity quantification. , 2016, Biomedical optics express.

[31]  Stephen A. Bopparr,et al.  Ultrahigh Resolution and Spectroscopic OCT Imaging of Cellular Morphology and Function , 2002 .

[32]  I. Rosset,et al.  Global Epidemiology of Dementia: Alzheimer's and Vascular Types , 2014, BioMed research international.

[33]  Tonny Lagerweij,et al.  A survey of clearing techniques for 3D imaging of tissues with special reference to connective tissue. , 2016, Progress in histochemistry and cytochemistry.

[34]  M. Villiger,et al.  Label-Free Imaging of Cerebral β-Amyloidosis with Extended-Focus Optical Coherence Microscopy , 2012, The Journal of Neuroscience.

[35]  Christian Humpel,et al.  Identifying and validating biomarkers for Alzheimer's disease , 2011, Trends in biotechnology.

[36]  Andrei G. Vlassenko,et al.  PET amyloid-beta imaging in preclinical Alzheimer's disease. , 2012, Biochimica et biophysica acta.

[37]  Wenzhong Liu,et al.  Colposcopic imaging using visible-light optical coherence tomography , 2017, Journal of biomedical optics.

[38]  Yu Song,et al.  Nondestructive evaluation of progressive neuronal changes in organotypic rat hippocampal slice cultures using ultrahigh-resolution optical coherence microscopy , 2014, Neurophotonics.

[39]  Frédéric Lesage,et al.  White matter segmentation by estimating tissue optical attenuation from volumetric OCT massive histology of whole rodent brains , 2017, BiOS.

[40]  J. Trojanowski,et al.  In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease , 2000, Neurobiology of Aging.

[41]  Emiri T. Mandeville,et al.  Optical coherence tractography using intrinsic contrast. , 2012, Optics letters.

[42]  C. V. D. van de Velde,et al.  Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens , 2017, PloS one.

[43]  Benjamin J Vakoc,et al.  Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging , 2009, Nature Medicine.

[44]  E. McVeigh,et al.  Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography , 2015, Science Translational Medicine.

[45]  J. Duker,et al.  Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. , 2004, Optics express.

[46]  G. Kovacs.  Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer? , 2016, Prion.

[47]  Bernhard Baumann,et al.  Extracting and compensating dispersion mismatch in ultrahigh-resolution Fourier domain OCT imaging of the retina. , 2012, Optics express.

[48]  Ryan P. McNabb,et al.  Method for single illumination source combined optical coherence tomography and fluorescence imaging of fluorescently labeled ocular structures in transgenic mice. , 2016, Experimental eye research.

[49]  Jeff W. Lichtman,et al.  Clarifying Tissue Clearing , 2015, Cell.

[50]  Michael R. Gardner,et al.  High-speed and high-sensitivity parallel spectral-domain optical coherence tomography using a supercontinuum light source. , 2016, Optics letters.

[51]  S. Gigan,et al.  Brain refractive index measured in vivo with high-NA defocus-corrected full-field OCT and consequences for two-photon microscopy. , 2011, Optics express.

[52]  Christoph K. Hitzenberger,et al.  Visualization of neuritic plaques in Alzheimer’s disease by polarization-sensitive optical coherence microscopy , 2017, Scientific Reports.

[53]  Philip G. Haydon,et al.  Multiphoton in vivo imaging of amyloid in animal models of Alzheimer’s disease , 2010, Neuropharmacology.

[54]  Daniil I. Nikitichev,et al.  Quantification of light attenuation in optically cleared mouse brains. , 2015, Journal of biomedical optics.

[55]  J G Fujimoto,et al.  Spectroscopic optical coherence tomography. , 2000, Optics letters.

[56]  Elizabeth M C Hillman,et al.  Optical brain imaging in vivo: techniques and applications from animal to man. , 2007, Journal of biomedical optics.

[57]  David A. Boas,et al.  Blockface histology with optical coherence tomography: A comparison with Nissl staining , 2014, NeuroImage.

[58]  Hans-Ulrich Dodt,et al.  Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy , 2015, PloS one.

[59]  Kwanghun Chung,et al.  Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems , 2015, Cell.

[60]  S C Gebhart,et al.  In vitro determination of normal and neoplastic human brain tissue optical properties using inverse adding-doubling , 2006, Physics in medicine and biology.

[61]  C. Jack,et al.  Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria , 2016, Alzheimer's & Dementia.

[62]  Marco Augustin,et al.  Visible light spectral domain optical coherence microscopy system for ex vivo imaging , 2017, BiOS.

[63]  Ji Yi,et al.  In vivo functional microangiography by visible-light optical coherence tomography. , 2014, Biomedical optics express.

[64]  J. Fujimoto,et al.  Spectroscopic optical coherence tomography. , 2000 .

[65]  Angelika Unterhuber,et al.  Imaging ex vivo healthy and pathological human brain tissue with ultra-high-resolution optical coherence tomography. , 2005, Journal of biomedical optics.

[66]  Georges Wagnières,et al.  Optical properties of rabbit brain in the red and near-infrared: changes observed under in vivo, postmortem, frozen, and formalin-fixated conditions , 2015, Journal of biomedical optics.